Bracey A W, Radovancević R
Department of Pathology, Texas Heart Institute, St Luke's Episcopal Hospital, Houston 77030.
Arch Pathol Lab Med. 1994 Apr;118(4):411-6.
Blood component therapy has always been important in coronary artery bypass grafting, and, initially, all patients undergoing bypass operations were given transfusions. The advent of hemodilution marked the beginning of blood conservation efforts that have reduced the transfusion requirements for these patients. We review the current state of cardiopulmonary bypass, blood loss, and blood use in coronary artery bypass grafting, including coagulation disturbances, preoperative autologous blood collection, blood conservation techniques, transfusion thresholds, blood component therapy, and blood use data.
血液成分疗法在冠状动脉旁路移植术中一直都很重要，最初，所有接受旁路手术的患者都要输血。血液稀释法的出现标志着血液保护工作的开始，这减少了这些患者的输血需求。我们回顾了冠状动脉旁路移植术中体外循环、失血和用血的现状，包括凝血功能紊乱、术前自体血采集、血液保护技术、输血阈值、血液成分疗法和用血数据。
